Search Results - "Younossi, Elena"

Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States by Paik, James M., Henry, Linda, De Avila, Leyla, Younossi, Elena, Racila, Andrei, Younossi, Zobair M.

“…Population‐level nonalcoholic fatty liver disease (NAFLD) death rate data are sparse. We described death rates for adults with NAFLD in the United States using…”
Get full text

The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19 by Stepanova, Maria, Lam, Brian, Younossi, Elena, Felix, Sean, Ziayee, Mariam, Price, Jillian, Pham, Huong, de Avila, Leyla, Terra, Kathy, Austin, Patrick, Jeffers, Thomas, Escheik, Carey, Golabi, Pegah, Cable, Rebecca, Srishord, Manirath, Venkatesan, Chapy, Henry, Linda, Gerber, Lynn, Younossi, Zobair M

“…COVID-19 outcomes among hospitalized patients may have changed due to new variants, therapies and vaccine availability. We assessed outcomes of adults…”
Get full text

A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) by Otgonsuren, Munkhzul, Estep, Michael J., Hossain, Nayeem, Younossi, Elena, Frost, Spencer, Henry, Linda, Hunt, Sharon, Fang, Yun, Goodman, Zachary, Younossi, Zobair M.

“…Background and Aim Non‐alcoholic steatohepatitis (NASH) is the progressive form of non‐alcoholic fatty liver disease (NAFLD). A liver biopsy is considered the…”
Get full text

Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection by Younossi, Zobair M., Stepanova, Maria, Lam, Brian, Cable, Rebecca, Felix, Sean, Jeffers, Thomas, Younossi, Elena, Pham, Huong, Srishord, Manirath, Austin, Patrick, Estep, Michael, Terra, Kathy, Escheik, Carey, Avila, Leyla, Golabi, Pegah, Kolacevski, Andrej, Racila, Andrei, Henry, Linda, Gerber, Lynn

“…The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown. Given the high prevalence of nonalcoholic…”
Get full text

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry by Younossi, Zobair M., Yilmaz, Yusuf, El‐Kassas, Mohamed, Duseja, Ajay, Hamid, Saeed, Esmat, Gamal, Méndez‐Sánchez, Nahum, Chan, Wah Kheong, Singal, Ashwani K., Lam, Brian, Felix, Sean, Younossi, Elena, Verma, Manisha, Price, Jillian K., Nader, Fatema, Younossi, Issah, Racila, Andrei, Stepanova, Maria

“…Patients with preexisting chronic liver disease (CLD) may experience a substantial burden from both coronavirus 2019 (COVID‐19) infection and pandemic‐related…”
Get full text

Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999–2016 by Golabi, Pegah, Paik, James M., Harring, Michael, Younossi, Elena, Kabbara, Khaled, Younossi, Zobair M.

“…Nonalcoholic fatty liver disease (NAFLD) subjects with fibrosis stage ≥2 are at high risk for mortality. We aimed to provide national estimates and temporal…”
Get full text

Performance of the Enhanced Liver Fibrosis (ELF) test in real world practice versus clinical trials of non-alcoholic steatohepatitis by Stepanova, Maria, Felix, Sean, Jeffers, Thomas, Younossi, Elena, Lam, Brian, Henry, Linda, Younossi, Zobair

Get full text

The combination of the ELF and FIB-4 scores have high predictive performance for significant fibrosis in patients with NAFLD by Younossi, Zobair, Felix, Sean, Jeffers, Thomas, Younossi, Elena, Nader, Fatema, Racila, Andrei, Lam, Brian, Stepanova, Maria

Get full text

The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease by Younossi, Zobair M., Stepanova, Maria, Felix, Sean, Jeffers, Thomas, Younossi, Elena, Goodman, Zachary, Racila, Andrei, Lam, Brian P., Henry, Linda

“…Summary Background The presence of fibrosis in NAFLD is the most significant risk factor for adverse outcomes. We determined the cutoff scores of two…”
Get full text

1121-P: The Combination of the ELF and FIB-4 Scores Have High Predictive Performance for Significant or Advanced Fibrosis in Patients with NAFLD by YOUNOSSI, ZOBAIR, FELIX, SEAN, JEFFERS, THOMAS, YOUNOSSI, ELENA, NADER, FATEMA, RACILA, ANDREI, LAM, BRIAN P., STEPANOVA, MARIA

“…Background: Patients with nonalcoholic fatty liver disease (NAFLD) and fibrosis stage ≥ 2 (F2-F4) are at risk for adverse outcomes and considered to be…”
Get full text

SAT-428 - Associations of genetic risk panel with enhanced liver fibrosis scores among patients with non-alcoholic fatty liver disease by Younossi, Zobair, Estep, James M, Felix, Sean, Younossi, Elena, Rao, Nagashree Gundu, Deavila, Leyla, Pham, Huong, Cable, Rebecca, Price, Jillian, Racila, Andrei, Stepanova, Maria

Get full text

Associations of genetic risk panel with enhanced liver fibrosis scores among patients with non-alcoholic fatty liver disease by Younossi, Zobair, Estep, James M, Felix, Sean, Younossi, Elena, Rao, Nagashree Gundu, Deavila, Leyla, Pham, Huong, Cable, Rebecca, Price, Jillian, Racila, Andrei, Stepanova, Maria

Get full text

Sa351 CARDIAC SERUM BIOMARKERS PREDICTING SEVERE CORONARY ARTERY DISEASE (CAD) AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) by Lam, Brian P., Jeffers, Thomas, Felix, Sean C., Younossi, Elena, Tran, Henry A.A., Stepanova, Maria, Nader, Fatema, Younossi, Zobair M.

Get full text

Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography by Younossi, Zobair M., Felix, Sean, Jeffers, Thomas, Younossi, Elena, Lam, Brian, Nader, Fatema, Tran, Henry A., Schneider, Ingrid, Stepanova, Maria

“…Cardiovascular disease is the most common cause of death among patients with nonalcoholic fatty liver disease (NAFLD). We assessed select cardiac biomarker…”
Get full text

Sa1612 – Mortality Related to Non-Alcoholic Fatty Liver Disease is Increasing in the United States Over the Last Decade by Paik, James, Henry, Linda, de Avila, Leyla, Younossi, Elena, Racila, Andrei, Younossi, Zobair M.

Get full text

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease by Younossi, Zobair M, Felix, Sean, Jeffers, Thomas, Younossi, Elena, Nader, Fatema, Pham, Huong, Afendy, Arian, Cable, Rebecca, Racila, Andrei, Younoszai, Zahra, Lam, Brian P, Golabi, Pegah, Henry, Linda, Stepanova, Maria

“…The most important surrogate for increased risk of adverse clinical outcomes among patients with nonalcoholic fatty liver disease (NAFLD) is the patient's…”
Get full text

976 Fibroscan™, FIB-4, and NAFLD Fibrosis Score as Point of Care Non-Invasive Tests for Management of Non-Alcoholic Fatty Liver Disease and Other Chronic Liver Diseases by Younossi, Zobair, Stepanova, Maria, Felix, Sean, Jeffers, Tom, Younossi, Elena, Allawi, Hossain, Cable, Rebecca, Lam, Brian, Racila, Andrei, Younossi, Issah, Henry, Linda, Ranagan, Jane, Nader, Fatema

“…INTRODUCTION: Fibroscan™ (FS) is a clinically useful tool for non-invasive assessment of fibrosis in patients with chronic liver disease (CLD). We aimed to…”
Get full text

Mo1413 - Outcomes of Wait-Listed Liver Transplant (Lt) Candidates with Hepatocellular Carcinoma (HCC) in the United States from 2001 to 2014 by de Avila, Leyla, Stepanova, Maria, Younossi, Elena, Racila, Andrei, Golabi, Pegah, Gogoll, Trevor, Younossi, Zobair M.

Get full text

Shear wave elastography, transient elastography and enhanced liver fibrosis test use in the assessment of non-alcoholic fatty liver disease (NAFLD) in real- world practices by Felix, Sean, Younossi, Elena, Jeffers, Thomas, Hudson, Evis, Rao, Nagashree Gundu, Chris, Z., Gandhi, Amish, Castillo-Catoni, Maria, Ramirez, Maria, Husain, Mehreen, Delgado, Evangeline, Baru, Ambika, Shrestha, Merica, Satchi, Romona, Gami, Yemsrach, Golabi, Pegah, Racila, Andrei, Nader, Fatema, Stepanova, Maria, Younossi, Zobair

Get full text

Negative impact of COVID-19 infection related to life disruption events and health scores on patients with chronic liver disease by Younossi, Zobair, Yılmaz, Yusuf, El Kassas, Mohamed, Duseja, Ajay Kumar, Hamid, Saeed Sadiq, Esmat, Gamal, Méndez-Sánchez, Nahum, Chan, Wah-Kheong, Singal, Ashwani, Ong, Janus, Lam, Brian, Felix, Sean, Younossi, Elena, Verma, Manisha, Price, Jillian, Nader, Fatema, Younossi, Issah, Racila, Andrei, Stepanova, Maria

Get full text